Therapeutic class: Intranasal corticosteroid (allergy-relief) Active ingredient: Fluticasone propionate Formulation: Sprayer (nasal spray) - 50 µg per actuation Regulatory status in Hong Kong: Prescription-only medicine, approved by the Hong Kong Department of Health (HKDH)
Fluticasone is a synthetic corticosteroid that reduces inflammation in the nasal passages. It is marketed worldwide as a generic nasal spray and is also available under several brand names. This article explains how fluticasone works, the conditions it is approved for, safety considerations, dosing recommendations, and practical FAQs for patients in Hong Kong.
Fluticasone belongs to the class of intranasal corticosteroids. When sprayed into the nose, it:
Because the spray is applied locally, systemic absorption is minimal, which limits the risk of typical oral-corticosteroid side effects. The onset of symptom relief usually occurs within 12 hours, with maximal effect after several days of regular use.
Fluticasone nasal spray is FDA/EMA/ HKDH-approved for the following adult indications:
It may also be used as an adjunct in the management of mild, persistent asthma when formulated as an inhaler, but the 50 µg nasal spray is specifically indicated for allergic rhinitis.
No robust peer-reviewed evidence supports off-label uses of the 50 µg nasal spray in Hong Kong. If a clinician considers an off-label indication, the decision must be based on individual risk assessment and specialist supervision.
Ideal candidates
Absolute contraindications
Relative contraindications
Special populations
If any of the above conditions apply, discuss alternatives with a healthcare professional.
| Interaction type | Example | Potential effect | |||| | CYP3A4 inhibitors | Ketoconazole, itraconazole, ritonavir | May increase systemic fluticasone levels; monitor for corticosteroid-related side effects. | | Live vaccines | Intranasal influenza vaccine | Intranasal corticosteroids can reduce vaccine efficacy; consider timing of vaccination. | | Strong CYP3A4 inducers | Rifampin, carbamazepine | May lower fluticasone exposure, reducing effectiveness. |
If you take other medicines, inform your pharmacist or physician before starting fluticasone.
Standard adult dosing (50 µg per spray):
Administration steps
Missed dose - Use the missed spray as soon as you remember, unless it is close to the time of the next scheduled dose. Do not double the dose.
Overdose - Signs may include severe nasal irritation, epistaxis, or systemic corticosteroid effects (e.g., weakness, facial swelling). Seek immediate medical attention; there is no specific antidote.
Discontinuation - Fluticasone may be stopped abruptly, but if you have been using high doses for many weeks, tapering can minimise rebound nasal congestion.
Special populations - No dose adjustment is required for patients with mild renal or hepatic impairment. Use with caution in severe organ dysfunction.
This article provides educational information about fluticasone and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Yes, fluticasone can be carried in your hand luggage. Keep the original packaging, ensure the bottle is sealed, and declare it if required by the destination country’s customs regulations.
The bottle is typically white or translucent with a clear plastic actuator. The label will display “Fluticasone 50 µg/spray” and the HKDH registration number. Inhalers for asthma have a different shape and dosage markings.
Fluticasone is a corticosteroid, not a controlled substance, and standard drug-testing panels do not screen for it. However, some sports organizations have specific rules regarding corticosteroid use; check the relevant anti-doping guidelines.
If you have a viral upper-respiratory infection without bacterial sinusitis, fluticasone can still be used to control allergy symptoms. Avoid it if you develop purulent nasal discharge or fever, and consult a clinician.
Typically 24 months from the manufacturing date, as indicated on the label. Always verify the expiration date before use.
Yes, intranasal fluticasone can be combined with oral antihistamines (e.g., cetirizine) for additive allergy relief. No direct pharmacokinetic interaction is known.
Both are potent corticosteroids with similar efficacy. Fluticasone’s 50 µg spray delivers a slightly lower per-actuation dose than mometasone’s typical 50 µg formulation, but clinical outcomes are comparable when used as directed.
In Hong Kong, the approved nasal spray contains fluticasone propionate 50 µg per actuation and is supplied in a metered-dose sprayer. Other countries may offer slightly different devices or concentrations.
Contact a healthcare professional. They may recommend a reduced dosing frequency, application of a saline rinse, or temporary discontinuation to assess the cause.
At the recommended intranasal dose, systemic absorption is minimal, and significant effects on blood pressure or glucose are rare. Patients with uncontrolled hypertension or diabetes should still discuss usage with their physician.
